Navigation Links
Aurora Biofuels Breakthrough Doubles CO2 Uptake and Fuel Production
Date:8/18/2009

New Molecular Toolkit Optimizes Algae Performance and Productivity

ALAMEDA, Calif., Aug. 18 /PRNewswire/ -- Today, Aurora Biofuels announces a technological milestone in the company's path to becoming the premier producer of low-cost advanced biofuels. Through a series of biotechnology achievements, Aurora has succeeded in optimizing its base algae strains to more than double CO2 consumption and fuel production, and has proven these results in an outdoor open system over the last several months.

Using tools developed in the fields of molecular biology and biochemistry, Aurora Biofuels scientists have developed a proprietary process which allows for the superior selection and breeding of non-transgenic algae. With this novel technique, the company has optimized its base algae strains with an increased ability to process sunlight and carbon dioxide into algal oil. As a result, these algae strains can produce more than twice the amount of oil. Optimized algae have been producing oil in Aurora Biofuels' outdoor pilot ponds for several months, providing strong evidence that these strains will remain robust at the industrial scale and remove more carbon emissions than previously thought possible.

"This is a major breakthrough showing that one can take algae with improved productivity from the research lab to the field. What Aurora scientists have achieved is an impressive milestone on the path to large-scale commercial algae production," said Kris Niyogi, a member of the company's scientific advisory board and professor of algal biology at the University of California, Berkeley.

"This is a game-changing development for our company, as our newly optimized algae, novel harvesting and extraction processes create a world-class, low-cost biofuel platform," said Bob Walsh, CEO of Aurora Biofuels. "There's a lot of noise about algae lately, but it's all talk until you prove it outdoors," he said. "This advancement, now proven for months in our pilot ponds, shows that we've met that rigid criteria and are now ready for the demonstration scale."

About Aurora Biofuels:

Aurora Biofuels manufactures fuel from optimized algae in a patented production process. Leading technologists at Aurora Biofuels have engineered a cost-competitive and scalable method for fuel generation, using robust and highly-productive custom algae strains. The Aurora Biofuels process is carbon-mitigating and non-competitive with agricultural resources, and capable of industrial yields with a minimal land requirement. Aurora Biofuels investors include: Oak Investment Partners, Noventi Ventures and Gabriel Venture Partners.


'/>"/>
SOURCE Aurora Biofuels
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
2. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
5. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
6. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
7. NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination
8. NexGen Biofuels Ltd. Announces Trading on OTC Bulletin Board
9. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
10. Performance Plants Establishes U.S. Biofuels Facility
11. NexGen Biofuels Ltd. Announces Plans to Replace its CFO With Local CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
Breaking Biology Technology:
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):